Militia Capital Partners’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$3.27M Sell
3,040
-1,060
-26% -$1.01M 0.75% 22
2025
Q3
$3.13M Buy
4,100
+2,000
+95% +$1.49M 0.76% 25
2025
Q2
$1.64M Buy
+2,100
New +$1.63M 0.38% 51

Other funds holding LLY

Militia Capital Partners's LLY Position: Q4 2025 in Review

Militia Capital Partners reduced its Eli Lilly (LLY) stake by 26% in Q4 2025, selling an estimated $1.01M and leaving 3,040 shares worth $3.27M. The position accounts for 0.75% of the portfolio, ranked #22.

Militia Capital Partners first reported a position in LLY in Q2 2025 and has held it in 3 quarters since. 4,445 funds tracked by Wall St. Rank hold LLY as of Q4 2025.

  • Militia Capital Partners held 3,040 shares of Eli Lilly worth $3.27M as of Q4 2025.
  • Militia Capital Partners sold 1,060 Eli Lilly shares in Q4 2025, an estimated $1.01M.
  • Eli Lilly made up 0.75% of Militia Capital Partners's portfolio in Q4 2025, its #22 holding.
  • Militia Capital Partners first reported a position in Eli Lilly in Q2 2025 and has held it in 3 quarters since.
  • 4,445 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2025.

Based on Militia Capital Partners's 13F filing for Q4 2025, filed 17 Feb 2026.